Turnstone Biologics Corp.
DelistedCIK 1764974fmd_01B5WFZ3XTMHA96C4JNM6P8A4QManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Jun 30, 2025, 14 periods
Latest annual · FY2023
Millions- Total revenues
- 19
- Operating income
- (72)
- Net income
- (71)
- Free cash flow
- (68)
Latest quarter · Q2 FY2025
Millions- Operating income
- (6)
- Net income
- (5)
Turnstone Biologics Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$72.5 million | -$59 million | 10-K 2025-03-31 · proof | |
| Net income | -$70.8 million | -$55.2 million | 10-K 2025-03-31 · proof | |
| Cash from operating activities | -$67.4 million | -$66.2 million | 10-K 2025-03-31 · proof | |
| Free cash flow | -$67.7 million | -$67.4 million | 10-K 2025-03-31 · proof | |
| Total assets | $40.1 million | $112.8 million | -64.4% | 10-K 2025-03-31 · proof |
| Total liabilities | $8.7 million | $14.1 million | -38.7% | 10-K 2025-03-31 · proof |
| Cash and cash equivalents | $28.9 million | $17.8 million | +62.5% | 10-K 2025-03-31 · proof |
- What was Turnstone Biologics Corp.'s operating income in fiscal 2024?
- Turnstone Biologics Corp. reported operating income of -$72.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$59 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What was Turnstone Biologics Corp.'s net income in fiscal 2024?
- Turnstone Biologics Corp. reported net income of -$70.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$55.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What was Turnstone Biologics Corp.'s cash from operating activities in fiscal 2024?
- Turnstone Biologics Corp. reported cash from operating activities of -$67.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$66.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What was Turnstone Biologics Corp.'s free cash flow in fiscal 2024?
- Turnstone Biologics Corp. reported free cash flow of -$67.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$67.4 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What are Turnstone Biologics Corp.'s total assets?
- As of Dec 31, 2024, Turnstone Biologics Corp. reported total assets of $40.1 million, against $112.8 million a year earlier (-64.4%). Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What are Turnstone Biologics Corp.'s total liabilities?
- As of Dec 31, 2024, Turnstone Biologics Corp. reported total liabilities of $8.7 million, against $14.1 million a year earlier (-38.7%). Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
- What are Turnstone Biologics Corp.'s cash and cash equivalents?
- As of Dec 31, 2024, Turnstone Biologics Corp. reported cash and cash equivalents of $28.9 million, against $17.8 million a year earlier (+62.5%). Source: the 10-K filed with the SEC on Mar 31, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1764974&period_type=annual&limit=5"Information only, not investment advice.